Investment NSW is providing support for Health and Medtech businesses looking to expand internationally in 2024-25. This information session is to learn about upcoming export support programs and discover how to apply.
Featured Speakers:
• Investment NSW Export Advisors
• NSW Health
• NSW International Expansion Programs 2024-25
• NSW Trade Investment Director USA – GGP Health to USA 2025
• NSW Trade Investment Director Korea – BioKorea 2025
• Senior Export Adviser – Opportunities in the UAE, India, Hong Kong, China Greater Bay Area, and Osaka Healthcare
• Case Study - Southern Star Research
• Case Study - Minomic International